Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review

BACKGROUND: Real-world comparisons of biologic treatment outcomes for ulcerative colitis (UC) or Crohn’s disease (CD) patients are limited. We sought to evaluate the real-world effectiveness of vedolizumab (VDZ) and anti-tumor necrosis factor alpha (anti-TNFα) in UC and CD patients in Germany. METHO...

Full description

Saved in:
Bibliographic Details
Published in:BMC Gastroenterol
Main Authors: Helwig, Ulf, Mross, Michael, Schubert, Stefan, Hartmann, Heinz, Brandes, Alina, Stein, Dara, Kempf, Christian, Knop, Jana, Campbell-Hill, Sarah, Ehehalt, Robert
Format: Artigo
Language:Inglês
Published: BioMed Central 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7341567/
https://ncbi.nlm.nih.gov/pubmed/32640990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01332-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items